Poul Knoblauch

Belinostat in Patients With Relapsed or Refractory Peripheral T-Cell Lymphoma: Results of the Pivotal Phase II BELIEF (CLN-19) Study

Owen A. O’Connor, Steven M. Horwitz, Tamás Masszi et al. · Journal of Clinical Oncology · 2015 · 547 citations · Full text

Medicine, Oncology, Pharmacotherapy +15

A Phase 1 Pharmacokinetic and Pharmacodynamic Study of the Histone Deacetylase Inhibitor Belinostat in Patients with Advanced Solid Tumors

Nicola Steele, Jane A. Plumb, Laura Vidal et al. · Clinical Cancer Research · 2008 · 243 citations · Full text

Medicine, Oncology, Pharmacology +14

A Phase <scp>II</scp> trial of Belinostat ( <scp>PXD</scp> 101) in patients with relapsed or refractory peripheral or cutaneous T‐cell lymphoma

Francine M. Foss, Ranjana H. Advani, Madeleine Duvic et al. · British Journal of Haematology · 2014 · 190 citations · Full text

Medicine, Oncology, Pharmacology +16

A phase I clinical trial of the histone deacetylase inhibitor belinostat in patients with advanced hematological neoplasia

Peter Gimsing, Mads Hansen, Lene Meldgaard Knudsen et al. · European Journal Of Haematology · 2008 · 161 citations

Medicine, Oncology, Pharmacology +8

Treatment of anthracycline extravasation with Savene (dexrazoxane): results from two prospective clinical multicentre studies

H.T. Mouridsen, Seppo W. Langer, Jan Buter et al. · Annals of Oncology · 2006 · 159 citations · Full text

Medicine, Oncology, Pharmacology +10